Skip to content

Study · Measured the body's own peptide · 2005

1 result

Galanin-like peptide stimulates vasopressin, oxytocin and adrenocorticotropic hormone release in rats.

Onaka T, Kuramochi M, Saito J, Ueta Y, Yada T

Neuroreport1 Feb 2005Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In male rats, intracerebroventricular galanin-like peptide significantly increased plasma concentrations of the body's own oxytocin.

    In plain wordsIn rats, galanin-like peptide injected into the brain raised the body's own oxytocin levels in blood.

    Peptide
    Oxytocin
    Outcome
    IncreasePlasma oxytocin after galanin-like peptide
    Study

    ratn: not reported in source

    Male rats with intracerebroventricular infusion
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    Intracerebroventricular injection of galanin-like peptide significantly increased plasma concentrations of vasopressin, oxytocin and adrenocorticotropic hormone.
    1 context sentence
    Summary · context
    We examined the effects of stressful stimuli on expression of c-Fos protein in galanin-like peptide neurons, and the effects of central infusion of galanin-like peptide on release of stress hormones, vasopressin, oxytocin and adrenocorticotropic hormone, in male rats.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.